Member Info for Laura2022

It is 100% PYC !!

This from 1hr ago and very carefully timed !!

Physiomics plc

1,696 followers

1h  Edited

We’re thrilled to continue our partnership with Cancer Research UK (CRUK) on an exciting new project! 🎉 We’ll be working on developing a PK/PD model to simulate the exposure-response relationship for a novel oncology therapy. This work will help guide the starting dose and dose range for an upcoming First-In-Human study. Looking forward to working together on this exciting project to advance #cancerresearch! Learn more 👉 https://lnkd.in/eSsmTv_m #PYC #oncology #news #biotech #pharma #dosing #cancer

Thanks Marchgt for the background information

Good luck and hope the recovery continues for all holders

Totally agree ofmesssage

They're cleaning up after 15yrs of Tory lies and corruption (particularly around Brexit and Covid)

Seems odd to wait 4 years to ask that

No thanks Amy

GEX has been mentioned by 4 different new posters now

Fits with the timing and the data /dosing work PYC do

“This new trial offers something different because researchers will use the DNA of participants to help them target treatments.” 

As part of the trial, every patient will have their genome sequenced, and the drug combination they receive will be based on the specific genetics of their cancer. As well as helping to target treatments, looking at the DNA of participants can also give researchers clues on how their cancers may have developed in the first place and how they behave.  

The adaptive design of the 5G platform trial, means that the drug combinations that are given to patients can be changed as real-time data is collected. So instead of sticking to one treatment plan that may quickly show signs of not helping treat the brain cancer, researchers will try multiple treatment options across different groups of patients which will help speed up the likelihood of finding a treatment plan that works best for that patient.

Kilkenny

I think a good chance it's linked

Kilkenny : last week or so

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that it has been awarded a new contract by an existing client Cancer Research UK. The project involves the development of Pharmacokinetic Pharmacodynamic (PK/PD)* model to simulate the exposure-response relationship for a novel oncology therapy to guide starting dose and dose range for an upcoming First in Human Study.

Pyc recently won a contract for first in human trials with cancer research UK

Maybe we are providing the dosing statistics?

A pioneering UK-wide trial has been awarded over £3m, by Cancer Research UK and the Minderoo Foundation, to test new treatments for people living with brain cancer.  

Maybe

But others think not

(See discussion this morning from 07.30am if that helps Kilkenny

I would have thought you'd be happy with the rise of nearly 50% over the last 6 weeks ?

Doesn't make sense to pull the plug

The British mining company Emmerson has appointed a syndicate of international and Moroccan banks to fund its mining operations in Khemisset, a town in northern Morocco.

According to converging reports, discussions between Emmerson and the banks indicate that the company will secure $310 million. 

The syndicate of banks includes ING Bank, Morocco’s Banque Centrale Populaire, Bank of Africa, and another international European Bank, reports indicate.

Reports further suggest that the funding will be split between multiple stakeholders, with the UK Export Finance providing $230 million, while the remaining $80 million will be obtained through different financing instruments.

Emmerson’s Chief Executive, Graham Clarke said: “We are delighted to have received strong demand for the project financing from both lenders and ECAs.

Thanks for all the invaluable research over the last 6 weeks

Real and actual price 0.32p to 0.36 and I can now sell my 1.7mln in one go

Up again

Leaderboard

£10k buy at 10.21am shown as sell is what started the move

With $1.7mln and cost cuts they have time and market has completely decimated EML as though it's ACP

Emmerson continues to examine its options with respect to the approvals process and will update the market shortly on its next steps.

Volume is coming and all EML need is some slightly positive updates which they said will be shortly